Finally, our results using large datasets from breast cancer patients revealed a significant association between high EPHA4 mRNA expression levels and poor patient outcome, as illustrated by the shortened relapse free survival in a large cohort of 1881 breast cancer patients. This evidence concerns the gene EPHA4 and breast carcinoma.